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Knvestigati5ns over the last four years have revealed 
that m~to~hondr~a possess asystem of considerable 
sophistication for the transport of Ca2* across their 
inner rnembrafles. In particular, itisnow apparent that 
a variety of mitochondria possess not only a uniport 
for the uptake of Ca” down its electrochemical gra- 
dient, but also a second Ca2* carrier which catalyzes a
continuous Ca2* efflux from the matrix against i s 
gradient of eI~~trochemica1 pote~t~a1. When A$ is in 
the physiological range, both carriers operate unidirec- 
tionall~ to permit eon~nuous recychng of Ca*” across 
the inner membrane, and thereby provide the basis for 
a kinetic regulation of the distribution of Ca2* between 
the cytosoi and the mitochondrial matrix. The purpose 
of this review is to examine the evidence for, and the 
consequences of, this cycling. 
Kinetic control carries with it three distinct advan- 
tages over any single carrier mechanism: 
(I) It enables the Ca’+ distribution to be controlled 
without changing either the A$ component or 
the ApB component of the proton electrochem- 
ical potential, and therefore without disturbing 
ATP synthesis or the distribution of metabolites. 
(2) It allows for flexibility of control, in that the dis- 
~r~but~on of Ca*’ may be regulated by a~t~ya~~n~ 
or inhibiting either or both of the pathways. 
(3) The system may be extremely sensitive, since rela- 
tively large changes in net flux of Ca’+ may resuit 
from relatively small changes in absolute carrier 
activity, 
2. The nature of the uptake and efffux pa~wa~s 
A der~onstrat~on of the distinct carrier for Ca2* 
efflux is that selective ~~~bi~~on of the Ca2+ uptake 
carrier by ru~en~urn ed causes anet efflux of accu- 
mulated CaZ’ f l--4]. This is not due to a rlo~-sp~~i~c 
leak of Ca2* from the matrix since the flux occurs 
against the gradient of Ca”+ electrochemical potential, 
i.e., when a high Aj, is retained [1,2]. Preservation of
A$ is an absolute prerequisite for the iden~ifjcatio~ 
of a physiolo~ca~ effiux pathway, as collapse of A$ 
wili allow net efflux to occur by reversal of the uptake 
carrier. In this respect he ~sens~~~~ty of an c&served 
effhx to ruthenium red may not in itseif be a suffi- 
cient criterion, since there is disagreement onwhether 
ruthenium red is an effective inhibitor of Ca2+ efffux 
via the normal uptake carrier under conditions of low 
AJ, ]5,61. 
To date, only two efflux pathways have been shown 
to fulfill these conditions. These are the Na”-dependent 
efflux from heart or brain mitochondria f2,4] @la, 
and the Na’independent effIux from liver mitochon- 
dria f1,3,7] f&lb. A number of agents induce Ca*+ 
release from ~toc~ondr~a in association with a co& 
lapse of A$; these will be considered in a separate 
section. 
Whiie the overalf effect of Na*-dependent and Na*- 
independent pathways on the regulation of Ca2+-distri- 
bution is very similar, their mechanisms are sufficiently 
distinctive to be considered separately, 
2.1. The &j&x and ~~~~~~ ~~w~~s in izearf and bn& 
rn~~~ch~~d~~ 
The efflux pathways in mitochondria of heart, 
skeletal muscle, brain, parotid gland, adrenal cortex 
and brown adipose tissue require Na+ for activity 
[‘Z-4,8,9]. The relation between carrier activity and 
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Fig.1. Schematic representation of ion movements across the 
mitochondr~al inner membrane during steady-state cycling. 
(a) Nat-dependent effiux (heart and brain mitochondria). 
(b) Na+-independent efflux (liver mitochondria). (i) Ca* uni- 
porter; (ii) Ca”-Na’ antiporter; (iii) Na’-H’ antiporter; 
(iv) respiratory chain; (v) Caz+-H’ net exchange. 
[Na’] is sigmoidal, giving Hill coefficients of 2-3, 
suggesting the involvement of 2 or more Na’ [4,8]. 
Half-maximal velocity is obtained with 7-12 mM Na+, 
depending on the tissue; K* cannot substitute for Na+, 
although some activity is shown by Li’ [3,4]. The 
V max of this carrier varies from 4- 18 nmol 
Ca” . min-’ . mg-’ at 25”C, being most rapid in 
heart and adrenal cortical mitochondria [3]. 
In the absence of Na+, a basal Ca’+ efflux of 
-I nmol Ca” . min-’ . mg-” can be observed in the 
presence of ruthenium red [2-41. However, the basal 
efflux is probably not due to residual activity of the 
Na’-dependent carrier since the two exhibit quite dif- 
ferent sensitivities to inhibition by the lanthanide 
series [lo]. The absolute requirement for Na+ for net 
efflux of Ca2+ in the presence of ruthenium red may 
be logically attributed to an obligatory exchange 
between Na’ and Ca2’ catalysed by a Na+-Ca2+ anti- 
porter. In agreement with this model, the carrier afso 
catalyses a 1: 1 exchange between intramitochondrial 
and extramitochondrial Ca2+, which is inhibited by 
Na’ [8]. Moreover, the Na*-induced effiux of Ca”I 
and the Ca*+--Ca’+ exchange are inhibited by La3+ to 
similar degrees. 
The existence of a Na’-H’ antiporter [ 111, which 
is distinct from the Na+--Ca’+ antiporter [ 121 would 
262 
enable Naf, that enters in exchange for Cazc, to efflux 
in exchange for I-i’, so that the overall exchange 
becomes Ca’” for H’, and this is observed in vitro. Net 
Ca*+-H+ exchange might suggest an alternative expia- 
nation of the Na+-requirement, namely that it reflects 
the dissipation by Na’ of a pH gradient which results 
from a direct exchange between Ca” and H’. How- 
ever, such an interpretation is made untenable by the 
fact that substitution of Na’ by K’ (plus nigericin) or 
by NH;, both of which dissipate ApH, does not induce 
Ca*+ release [2,4]. 
The stoichiometry of Na+-Ca*+ exchange has not 
been determined, but the kinetic data referred to 
above indicate the involvement of 22 Na+/cycle of 
exchange with Ca’+, and such a stoichiometry would 
allow the necessary extrusion of Ca2’ against its gra- 
dient of electrochemical potential. The function of 
the antiporter in specifically catatysing efflux of Ca’+ 
is emphasized by the observation that the Vmax of 
Na’-induced efflux of Ca2+ is stimulated 2-3-fold by 
coupled respiration [8J. 
The existence of a Na+-Ca*+ antiporter is sufficient 
to explain earlier reports [ 13- 151 of the release or 
decreased accumulation of Ca” by heart mitochondria 
in the presence of Na’. 
The nature of the uptake pathway in cardiac mito- 
chondria has been estabIished by thermodyrlarnic 
analysis under conditions where the efflux carrier is 
inactive (in the absence of Na‘) and the uptake carrier 
is highly active (at high extramitochondrial [Ca*‘]) [ 12). 
Under these conditions the uptake pathway would be 
predicted to approach equilibrium. In the case of Ca2+ 
uniport, the equilibrium distribution would be pre- 
dicted to obey the Nernst equation: 
2.3Rrlog ICaZ+lmatrix 
A$=- 
nF ICa2+lo,t 
(1) 
where N, the net charge transfer/Ca2’ transported, 
would equal 2. Quite different distributions are pre- 
dicted for other mechanisms [7,16]. 
By determining the extramitochondrial free [Ca”‘] 
required to maintain a constant ~ntra~nitochondrial 
free [Ca”] as A$ is varied, both n (eq. (1)) and the 
intramitochondrial free [Ca*‘] may be determined. 
The technique has provided a value of 1 .X-2.1 for n, 
indicating a uniport mechanism, and 0.7-l .9 mM for 
the free intramitochondrial [Ca”] with total matrix 
Ca2+ contents of 25-39 nmol/mg protein [ 121. 
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In cardiac mitochondria, the relation between the 
activity of the uniporter and the extramitochondrial 
free [Ca*‘] is hyperbolic (Km lo- 15 PM), and 
becomes sigmoidal in the presence of Mg*+ [ 171. 
Although Pi augments the initial rate of Ca2+ influx 
[ 171 when succinate is the substrate, this phenomenon 
appears to reflect an effect of Pi on succinate oxida- 
tion, rather than on Ca*’ transport itself [ 181. 
The Na+-Ca*+ and Na’-H’ antiporters may be 
integrated, together with the Ca*’ uniporter and the 
respiratory chain into the cycle shown in fig.la. 
2.2. The efflux and uptake pathways in liver mito- 
chondria 
Mitochondria from liver, kidney, smooth muscle 
and lung possess a ruthenium red-insensitive efflux 
carrier which ejects Ca*+ against its electrochemical 
gradient in the absence of Na’ [ 1,3]. The V,, at 
25°C varies from 20 nmol Ca*+ . min-’ mg-’ in 
kidney to 3 nmol . min-’ mg-’ in smooth muscle 
[3]. The absence of a means of modulating the activ- 
ity of efflux from these mitochondria has limited 
direct investigation of its kinetics and mechanism. 
Instead, most evidence for the existence of this path- 
way has been provided by observing the conditions 
under which the steady-state Ca*+ distribution either 
conforms to, or deviates from, that predicted for a 
Ca*+ uniport [1,7,19]. 
Early evidence for a uniport mechanism for the 
Ca*+ influx carrier in liver mitochondria was obtained 
by Selwyn et al. [20] who demonstrated a rapid 
respiration-independent swelling in iso-osmotic 
Ca(CNS),, whereas swelling in calcium acetate was 
dependent on the addition of a proton translocator. 
In addition, Scarpa and Azzone [21] reported that 
the influx of Ca2+ induced by a K’ diffusion potential 
in the presence of valinomycin occurred with a stoi- 
cheiometry of 2 K’: 1 Ca*+ (see also [22]). 
The Ca*’ uniporter in liver mitochondria is more 
active than observed in most preparations of heart 
mitochondria [2,23]. In particular, when the extra- 
mitochondrial free [Ca”] is 24 PM, the uniporter 
ceases to be rate limiting during net Ca*+ accumula- 
tion, and instead the rate at which the respiratory 
chain can expel protons becomes the limiting factor 
[7,16]. This prevents meaningfulK, values from being 
obtained. There is some disagreement as to whether 
the carrier shows sigmoidal kinetics in the absence of 
added Mg*+ [24-271, although in the presence of 
Mg2+ the kinetics are certainly sigmoidal [25,27]. 
Thus, as for heart (section 2.1), one predicts a pro- 
nounced dependency of the activity of the uniporter 
on changes in the cytosolic free [Ca”] in the physi- 
ological range. 
Alternative mechanisms for Ca*+ uptake have been 
proposed, including a Ca’+/H+ antiport [26], a 
2 Ca*+-P:- symport [28,29] and a Ca*‘-fi-hydroxy- 
butyrate- symport [30]. As Pi and /3-hydroxybutyrate 
each equilibrate with ApH, these three mechanisms 
are thermodynamically equivalent. The equilibrium 
free [Ca”] gradient which can be maintained by these 
mechanisms is considerably less than that resulting 
from a Ca*+ uniport [2,16]. Thus, even without con- 
sidering the effect of an independent efflux pathway, 
the observed matrix Ca*’ content could only be 
reconciled with these proposals if an improbably low 
activity coefficient (3-8 X 1 O-“) is assumed for the 
matrix Ca2+ [7]. 
Puskin et al. [l] investigated the steady-state dis- 
tribution of Mn*+, a paramagnetic analogue of Ca2+, 
as a function of A$. The use of Mn*’ enables free and 
bound intramitochondrial Mn*+ to be distinguished 
by EPR [30,3 11. When A+ was <80 mV and extra- 
mitochondrial Mn” was high, the values of n (eq. (1)) 
obtained were 1.8-l .94, i.e.,very close to 2, the value 
predicted by a uniport mechanism [ 11. As A$ was 
increased the distribution of free Mn*+ deviated 
increasingly from the Nernst equation (l), such that 
at 160 mV the accumulation ratio of free Mn*’ was 
only 1% of that predicted [ 11. 
In contrast to Mn*‘, the activity coefficient of 
Ca*+ in the matrix of liver mitochondria has not been 
determined directly. However, the steady-state distri- 
bution of Ca*’ at low A$ and high extramitochondrial 
free Ca” was found to be consistent with an n value 
of 2 (eq. (1)) if an activity coefficient of 0.1 was 
assumed [7]. A similar conclusion was reached by 
Rottenberg and Scarpa [32] although activity coeffi- 
cients of unity were assumed for both matrix and 
extramitochondrial compartments. As with Mn*+, the 
distribution of Ca*’ becomes increasingly non- 
Nernstian as A$ is increased and extramitochondrial 
free [Ca”] is decreased [7]. Eventually the distribu- 
tion becomes independent of membrane potential [7]. 
The observed deviations from Nernstian behaviour 
can be explained by the existence of an independent 
efflux pathway in addition to the uniporter (table 1). 
At 2.7 PM extramitochondrial free Ca2’ the initial 
rate of Ca*+ uptake (v+r in table 1) is -109 nmol 
Ca’+ . min-’ mg-’ at 30°C [7]. If A$ is such that a 
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Table 1 
Steady-state Ca*+ cycling: the extent of deviation of the Ca*+ unipocter from 
equilibrium as a function of the free fCa*] 
[@+I0 
CPM) 
v+* v 1 V-2 
(nmol Ca’+ . mitt-‘. mg-‘) 
~_ 
2.7 110 109 104 5.0 1.05 
1.1 120 13 8.0 5.0 1.63 
0.77 130 5.5 0.5 5.0 11 
0.74 140 5.0-5.1 GO.1 5.0 a50 
v+’ and v-l are, respectively, the forward and reverse velocities of Ca* flux via the uni- 
porter (v+t - Y-t = net influx); v-’ is the velocity of efflux via the independent pathway. 
Data were taken from [7] and refer to rat liver mitochondria at 30°C and pH 7.0. 
[Caz+IO is the steady-state free CaZf concentration maintained in the incubation by the 
mitochondria. [Ca”] and A$ were varied by increasing the Ca*+ in the incubation in the 
presence of limiting Pi. v+’ was cafculated from the dependency of the uniport activity on 
[CaPI [7]; V-* was assumed to be constant; V-’ was calculated by difference 
0 
March 1980 
steady-state is attained with this concentration of 
extramitochondrial free Ca2*, and if an independent 
efflux (v-2 in table 1) of 5 nmot Ca’+ . min-’ . mg-’ 
occurs 17,333 then efflux by reversal of the uni- 
porter (v-l) must be occurring at 104 nmol Ca2+ .
min -’ . mg -’ . The uniporter is thus very close to 
equilibrium, i.e ., Y+’ /v -’ is close to 1, and a Nernst 
distribution is approached. The activity of the uni- 
porter in liver l~itochondria is highly dependent on 
the extramitochondrial free [Ca”] in the ,uM range 
[7,24-27,341, and if the extramitochondrial free 
[Ca’+] is reduced to 0.7 MM, and A$ is increased to 
retain steady-state conditions, then the initial rate of 
Ca” uptake through the uniporter is kinetically 
limited to 5.5 nmol Ca2+ . min-’ . mg-’ [7] . As the 
activity of the independent efflux pathway in liver is 
independent of the extramitochondrial free [Ca”‘], 
such that even addition of EGTA does not increase 
the efflux rate [I], ve2 will remain constant at 
5 nmol Ca*+ . min-’ . mg- r. Clearly, efflux by reversal 
of the uniporter must be occurring at only 0.5 nmol 
Ca2+ .min-’ . mg-‘. The ratio v+‘/v-r is thusno longer 
close to unity and the uniporter is no longer operating 
close to equilibrium. The extreme case is attained when 
the extramitochondrial free [Ca”] is reduced still 
further so that v+r = vm2 , i.e., v-* becomes very small 
(table 1). 
An increased deviation from Nernstian behaviour 
has also been observed when the activity of the uni- 
porter is restricted, not by decreasing the extramito- 
chondrial free Ca2’, but by titration with low concen- 
trations of ru~enium red [ 151. 
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Although the mechanism of the Ca2’ efflux path- 
way in liver is not established, Ca2’ efflux must 
ultimateiy be linked to proton re-entry to permit con- 
tinuous operation of a cyclic pathway (fig.lb). A 
Ca2’/2 H+ antiport has been proposed by Fiskum and 
Lehninger [35] based on the observation that Ca*’ 
efflux induced by acetoacetate in the presence of 
ruthenium red (section 3) is associated with the 
re-uptake of 2 H’/Ca’*. However, interpretation of 
these results, in terms of a strict exchange of protons 
for Ca” via the efflux carrier, is complicated by the 
proton permeability and consequent membrane poten- 
tial collapse induced by acetoacetate under these con- 
ditions ([36] and see section 3). 
3 I Calcium efflux induced by lowered membrane 
potential 
In addition to the Ca2+ efilux that may be seen at 
high A$, and which may be attributed unequivocally 
to the operation of an independent mechanism, net 
Ca2’ efflux may also be induced by agents which 
lower A$ and thereby allow net efflux via the uni- 
porter. Proton translocators clearly belong to this 
category. 
The membrane potential may also be lowered, 
without decreasing Afl,., by increasing the pH gra. 
dient. When Ca*+ is accumulated by liver mitochondria 
in the presence of N-ethylmaleimide, to prevent Pi 
transport and concomitant ApH dissipation (section 4), 
accumulation is folfowed by a partial loss of Ca” [37], 
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This has been interpreted as evidence for Ca*’ 
cycling 1371; however, the loss of Ca*+ is paralleled 
by a time-dependent decrease in A$ which is suffi- 
cient to account for the observed loss of Ca2+ by 
re-equilibration via the uniporter (371. 
The third class of agents which lower A$ are those 
that induce gross structural damage, characterized by 
their time dependency,loss of inner-membrane irnper- 
meability to NADH [38], net depletion of matrix 
adenine nucleotide 139,401, decreased light scattering 
[41,42] and loss of respiratory control. High [Ca”], 
in the presence of Pi, may induce such damage, and 
the effect is potentiated by agents such as phospho- 
enolpyruvate 143-461, atractylate [47] and carboxy- 
atractylate 1481. Increased oxidation of the matrix 
nicotinamide nucleotide pool, e.g., by acetoacetate 
addition to liver mitochondria, induces a net efflux of 
Ca*’ which has been proposed to result from activa- 
tion of an independent efflux pathway [35,49]. How- 
ever, it has been shown that the efflux is accompanied 
by a collapse of the membrane potential and a loss of 
respiratory control f36], both of which exhibit a 
dependency on [Ca*+] similar to that induced by 
phosphoenolpyruvate [45]. 
Tumour mitochondria [.5O,Sl] and mitochondria 
prepared from the livers of glucagon-pretreated rats 
152,531 are unusually resistant to the structural 
damage induced by high [Ca”] in the presence of Pi. 
Agents which stabilize the mitochondria against 
damage induced by high [Ca2”] include ATP, ADP, 
bongkrekate and oligomycin [40,44,48,54]. ATP is 
able to prevent the sensitization induced by phospho- 
enolpyruvate [43] or nicotinamide nucleotide oxida- 
tion 1361. The molecular bases of these effects are 
unknown. It would be predicted that the cytosolic 
adenine nucleotide concentrations pertaining in vivo 
would be sufficient to prevent such mitochondrial 
damage occurring under physiologic~ conditions. It 
should be emphasised that the Na’dependent and 
Na+-independent efflux pathways depicted in section 2 
and which operate at high membrane potential con- 
tinue to function in the presence of exogenous adenine 
nucleotides. 
4. The net accumulation of calcium 
When the extramitochondrial free [Ca*‘] is suffi- 
ciently high for the activity of the uniporter to exceed 
that of the efflux pathway, net Ca*+ accumulation 
occurs. The entry of positive charge lowers A$ 
[55,56] and allows net proton extrusion by the respi- 
ratory chain to occur with a consequent increase in 
API-I until ApH+ is restored. In the strict absence of 
other ion movements a Hf/Caz’ ratio of 2 is observed 
[12,57,58]. It should be noted that this ratio in itself 
is not unambiguous evidence that Ca*+ accumulation 
occurs via a uniport mechanism, since the same stoi- 
cheiometry would result, e.g., from a Ca*‘/ 1 H’ anti- 
port linked to the extrusion of 1 proton by the respi- 
ratory chain. The capacity of the mitochondria to 
accumulate Ca*’ is limited under these conditions to 
-20 nmol Ca*‘/mg [7,59] by the decrease in A$ 
resulting from the relatively low intramitochondrial 
pH buffering capacity [56]. 
The presence of anions which can permeate by 
proton symport (or OH- antiport) diminishes the 
increase in ApH as CaZC is accumulated, due to the 
parallel uptake of the anion. The capacity of mito- 
chondria to accumulate Ca*+ is thus enhanced and 
the H+/Ca” ratio is decreased towards zero 1601. 
The case of Pi is complicated by the formation of 
Ca3(P04)* in the matrix. A H’/Ca** ratio of -1 is 
obtained [60], although the matrix pH does not 
increase. Most mitochondrial preparations contain 
some endogenous Pi, redistribution of which can be 
prevented by ~~thylm~eimide or mersalyl 1611, 
These agents therefore decrease the capacity of mito- 
chondria to accumulate Ca*’ even in the absence of 
added Pi [7,62]. 
The transient decrease in A$ during net Ca*+ accu” 
mulation stimulates respiration [54]. At high [Ca”] 
the resultant lowered ApH+ may be insufficient for 
ATP synthesis, and may even allow hydrolysis of 
matrix ATP [63]. In the latter case, the consequent 
H” extrusion by the ATP synthase is additional to that 
occurring due to respiration, with the result that 
apparently ‘super-stoicheiometri~’ Ca*‘/O ratios may 
be observed [64]. 
5. The steady-state cycling of calcium 
The simultaneous operation of independent uptake 
and efflux pathways across the inner membrane results 
in the continuous cycling of Ca*+ between the cytosolic 
and matrix compartments. As shown in fig.1 a,b, Ca’+ 
cycling is associated with a continuous dissipation of 
Air,+, and thus a fraction of the respiration is utilized 
to drive recycling. An inhibition of state 4 respiration 
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has been observed when Ca*’ cycling is inhibited by 
addition of ruthenium red to both liver and heart 
mitochondria [4,33]. The extent of energy dissipation 
is not large and accounts for <2% of the state 3 respi- 
ration of brain, adrenal cortical or liver mitochondria 
[4,331. 
At pH 7.0 and 3O”C, steady-state Ca*’ cycling is 
attained by liver mitochondria when the extramito- 
chondrial free [Ca”] is -0.8 PM [7], and by brain 
mitochondria in the absence of Na’ when the free 
[Ca”] is 0.3 PM [48]. Slight displacements in free 
[Ca”] above or below these values are countered by 
net uptake or release of Ca*+ to restore the initial 
steady-state xtramitochondrial free [Ca”] [7]. As 
long as the membrane potential is maintained, the 
steady-state xtramitochondrial free [Ca”+] does not 
vary significantly when the total matrix [Ca”] 
changes within wide limits [7,48]. Thus brain mito- 
chondria in the presence of Pi can increase their matrix 
Ca*’ content from 20-200 nmol/mg while the extra- 
mitochondrial free [Ca’+] maintained in the steady- 
state increases by <lo% [48]. The mitochondria 
therefore act as almost perfect buffers of extramito- 
chondrial free [Ca”]. 
When Na’ is added to brain or heart mitochondria 
in order to activate the efflux pathway, there is a 
transient net efflux of Ca*+ ([4,48]; fig.2). Net efflux 
increases the extramitochondrial free [Ca”‘] and this 
in turn allows the velocity of the uniporter to increase 
until a new steady-state is attained. The mitochondria 
will subsequently buffer the extramitochondrial free 
[Ca”] at this new steady-state (fig.2). Partial inhibi- 
tion of the uniporter by Mg*+ also increases the 
steady-state xtramitochondrial free [Ca*+],e.g., 1 mM 
[Cal, PM mite 
Bni & 
0.2J 
?a t Co Ca Ca 
NaCl IOmM 
I 4 
5 mm 
Fig.2. The effect of Na* on the steadystate free [Ca*+] main- 
tained by mitochondria from guinea-pig cerebral cortex. For 
experimental details see [48]. Each Ca*+ addition was of 
25 nmol/mg. The incubation contained 2.3 mM Pi, 0.2 mM 
ATP and 2 Gg/ml oligomycin. 
Mg’+ increases the steady-state free [Ca’+] maintained 
by liver mitochondria from 0.8-l .8 PM [7]. 
6. Physiological implications of mitochondrial Ca’+ 
cycling 
If mitochondria cycle Ca*’ across their inner mem- 
brane in viva, a number of predictions can be made. 
The simplest case to consider is a closed system where 
the total Ca*+content incytosol plus matrixis constant. 
Under these conditions the steady-state distribution 
of Ca*’ between cytosol and matrix can be altered by 
modulating the activity of either the uptake or efflux 
pathway. Any change in the Ca*’ content of the 
cytosol is of course accompanied by an inverse change 
in the matrix Ca*’ content in the closed system. Mito- 
chondria are thus in theory capable of regulating the 
total Ca*+ content, and by extension the free [Ca”], 
in either compartment. It has been suggested that the 
action of cu-adrenergic agonists on hepatocytes may 
involve such an internal redistribution of cellular 
Ca*+ [65]. 
If the system is perturbed by a net addition or 
removal of Ca*+, e.g., by net flux of Ca*+ across the 
plasma membrane, the mitochondria will seek to 
restore steady-state recycling and, in doing so, the 
distribution of Ca*+ across the inner membrane will 
be changed. The resultant distribution will depend on 
the tissue load of Ca*+, and two such cases may be 
considered in relation to the work of Brinley et al. 
[66] who imposed varying Ca*+ loads on squid axons. 
Firstly, one may consider the steady-state case in 
which the cytosolic [Ca”] is sufficiently high so that 
the activity of the uniporter approaches the V,, of 
the efflux process. The efflux process will be essen- 
tially saturated with matrix Ca*’ and will have a con- 
stant activity irrespective of the Ca*+ distribution. If 
the cytosolic [Ca’+] is changed, restoration of the 
steady-state can only be achieved when the uniporter 
regains its former activity, i.e., when the former 
cytosolic [Ca”] is regained. In other words, the mito- 
chondria will selectively buffer cytosolic [Ca”], 
losing or accumulating Ca*’ until the initial cytosolic 
[Ca*‘] is restored. When the tendency towards 
reattainment of the steady state is opposed by a con- 
tinuous influx of Ca” into the cell, for example, the 
cytosolic [Ca”] will be buffered at a value that per- 
mits net influx into the mitochondria to keep pace 
with influx across the plasma membrane. In fact, this 
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behaviour has been observed during continuous 
loading of squid axons with Ca2+ [66]. When the 
mitochondria were functional the cytosolic free [Ca”+] 
was buffered between l-3 PM, while the total axonal 
[Ca’+] increased from 0.1-2 mM. 
In contrast to the above case, if the cytosolic [Ca”] 
is sufficiently low, the rate of Ca*+ influx via the uni- 
porter will be equalled by extrusion via the efflux 
process at non-saturating matrix free [Ca”]. Under 
these conditions, the initial cytosolic free [Ca”] will 
not be regained following a perturbation. For example, 
an increase in uniporter activity, following a rise in 
cytosolic [Ca’+], will cause the matrix [Ca’+] to 
increase and this, in turn, will increase the activity of 
the efflux pathway. Thus, the increase in uniporter 
activity will be matched by an equivalent increase in 
the activity of the efflux pathway, and a new steady- 
state will be attained with a higher cytosolic free 
[Ca”‘]. In other words, the mitochondria will have a 
diminished capacity to buffer cytosolic [Ca”]. In 
agreement with this prediction, axonal mitochondria 
exhibit negligible capacity to buffer extramitochon- 
drial free Ca*+ at <0.2-0.3 PM [66]. On the other 
hand, the loss in buffering capacity for extramito- 
chondrial [Ca’+] will be accompanied by a gain in 
control of matrix free [Ca”+], since changes in this 
will be limited by the consequent change in activity 
of the efflux pathway. 
Mitochondrial Ca’+ cycling therefore provides for 
versatile regulation of the distribution of cellular Ca*+. 
It allows in theory for control of the intramitochon- 
drial free [Ca”+], and the possible need for such con- 
trol emerges from recent work demonstrating regula- 
tion of several dehydrogenases of the citric acid cycle 
invitro by changes in free [Ca”‘] [67-691. Mitochon- 
drial Ca2+ cycling also provides a means of buffering 
the extramitochondrial [Ca”] if this is above certain 
limits. 
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